Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors

Marina Gobbe Moschetta, Larissa Bazela Maschio, Bruna Victorasso Jardim-Perassi, Gabriela Bottaro Gelaleti, Juliana Ramos Lopes, Camila Leonel, Naiane Do Nascimento Goncalves, Livia Carvalho Ferreira, Gustavo Rodrigues Martins, Thaiz Ferraz Borin, Debora Aparecida Pires De Campos Zuccari

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Mammary tumors are the most common type of tumor in dogs, with approximately half of these tumors being malignant. Hypoxia, characterized by oxygen levels below normal, is a known adverse factor to cancer treatment. The hypoxia-inducible factor 1α (HIF-1α) is a central regulator of the pathophysiological response of mammalian cells to low oxygen levels. HIF-1α activates the transcription of vascular endothelial growth factor (VEGF), which in turn promotes angiogenesis through its ability to stimulate the growth, migration and invasion of endothelial cells to form new blood vessels, contributing to tumor progression. In this study, we evaluated the serum concentration and gene expression of VEGF and HIF-1α linking them with clinicopathological parameters and survival of dogs with mammary tumors in order to infer the possible prognostic value of these factors. We collected blood and tumor fragments of 24 female dogs with malignant mammary tumors (study group) and 26 non-affected female dogs (control group) to verify the gene expression of VEGF and HIF-1α by quantitative real-time PCR (qPCR) and the serum levels by ELISA (enzyme-linked immunosorbent). The results showed high serum levels of VEGF in the study group and its correlation between abundant vascularization, lymph node involvement, metastasis, death rate and low survival (p<0.05). The serum percentage of HIF-1α in female dogs with mammary neoplasia was lower than that in the control group and higher in female dogs with tumor metastasis and history of tumor recurrence (p<0.05). Regarding gene expression, there was a gene overexpression of VEGFA in female dogs with poor outcome, in contrast to the gene underexpression of HIF-1A. Taken together, these results suggested that VEGF is important in tumor progression and can be used as a potential prognostic marker in the clinic and may be useful in predicting tumor progression in dogs with mammary neoplasia.

Original languageEnglish (US)
Pages (from-to)2345-2353
Number of pages9
JournalOncology Reports
Volume33
Issue number5
DOIs
StatePublished - May 1 2015
Externally publishedYes

Keywords

  • Angiogenesis
  • Canine mammary tumors
  • Hypoxiainducible factor-1α
  • Prognostic markers
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors'. Together they form a unique fingerprint.

  • Cite this

    Moschetta, M. G., Maschio, L. B., Jardim-Perassi, B. V., Gelaleti, G. B., Lopes, J. R., Leonel, C., Do Nascimento Goncalves, N., Ferreira, L. C., Martins, G. R., Borin, T. F., & De Campos Zuccari, D. A. P. (2015). Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors. Oncology Reports, 33(5), 2345-2353. https://doi.org/10.3892/or.2015.3856